Pfizer Begins Trials of Omicron Booster
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant.
Banker & Tradesman’s Editorial Cartoon: A Little Jab
by Peter Paul Payack | Dec 20, 2020
But, Mr. President! This is the treatment you yourself recommended to the people!
Most Popular | Most Recent
- Mass. Should Say: ‘Yes in God’s Backyard’
- Fidelity Invests in Seaport’s Retail Reinvention
- Brookline Bank Continues to Shrink CRE Portfolio
- Industrial Tenants Focus on Cost Reduction
- Seyon Group Acquires Ninth Building in Shawmut Park
- Eastern Bank to Buy HarborOne in $490M Deal
- Hines Joins 5M SF Development in Alewife Quad
- Downtown Boston’s 99 High St. Sells for $227M
- Berkshire Bank Sees Net Income Growth to Start 2025
- Boston Wants Proposals for Brighton Site Donated by Lab Developer
- Eastern Bank to Buy HarborOne in $490M Deal 63 views
- Boston Wants Proposals for Brighton Site Donated by Lab Developer 43 views
- Hines Joins 5M SF Development in Alewife Quad 27 views
- Brookline Bank Continues to Shrink CRE Portfolio 17 views
- Downtown Boston’s 99 High St. Sells for $227M 17 views
- On Linnaean Street, a Divide that Helps Keep Housing Costly 16 views
- Industrial Tenants Focus on Cost Reduction 13 views
- Seyon Group Acquires Ninth Building in Shawmut Park 13 views
- Judge Says BPDA Overstepped Power in Holding Up Development 11 views
- Dorchester Development Battle Heads to Court 11 views